Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Seattle Genetics Gains After Analyst Raises Sales Estimate for Cancer Drug
Seattle Genetics Gains After Analyst Raises Sales Estimate for Cancer Drug
Seattle Genetics Gains After Analyst Raises Sales Estimate for Cancer Drug
Submitted by
admin
on November 28, 2011 - 4:47pm
Source:
Bloomberg
News Tags:
Seattle Genetics
Hodgkin's lymphoma
Adcetris
Headline:
Seattle Genetics Gains After Analyst Raises Sales Estimate for Cancer Drug
Do Not Allow Advertisers to Use My Personal information
